tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

Yum! Brands upgraded, Chipotle downgraded: Wall Street’s top analyst calls
The FlyYum! Brands upgraded, Chipotle downgraded: Wall Street’s top analyst calls
1h ago
T
CAG
Canaccord starts BridgeBio on Attruby launch, pipeline
PremiumThe Fly
Canaccord starts BridgeBio on Attruby launch, pipeline
6h ago
BBIO
BridgeBio initiated with a Buy at Canaccord
PremiumThe Fly
BridgeBio initiated with a Buy at Canaccord
7h ago
BBIO
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
PremiumWeekend Updates
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
4d ago
GE
BBIO
BridgeBio price target raised to $98 from $94 at Morgan Stanley
PremiumThe Fly
BridgeBio price target raised to $98 from $94 at Morgan Stanley
6d ago
BBIO
Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data
PremiumRatingsAnalyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data
7d ago
BBIO
BridgeBio Wins FDA Priority Review for BBP-418 Therapy
Premium
Company Announcements
BridgeBio Wins FDA Priority Review for BBP-418 Therapy
7d ago
8K
BBIO
BridgeBio announces FDA acceptance, priority review of BBP-418 NDA
Premium
The Fly
BridgeBio announces FDA acceptance, priority review of BBP-418 NDA
7d ago
BBIO
Intel downgraded, Marvell upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Intel downgraded, Marvell upgraded: Wall Street’s top analyst calls
8d ago
CI
DT
Video: Eli Lilly rises after vaccine acquisitions
PremiumThe Fly
Video: Eli Lilly rises after vaccine acquisitions
8d ago
AZO
BAH
BridgeBio downgraded to Market Perform from Outperform at Raymond James
PremiumThe Fly
BridgeBio downgraded to Market Perform from Outperform at Raymond James
8d ago
BBIO
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
15d ago
AMT
BAP
BridgeBio initiated with a Neutral at Citi
PremiumThe FlyBridgeBio initiated with a Neutral at Citi
16d ago
BBIO
BridgeBio Files FDA NDA for Encaleret in ADH1
Premium
Company Announcements
BridgeBio Files FDA NDA for Encaleret in ADH1
21d ago
8K
BBIO
BridgeBio shares have ‘clear path’ to $90s, says JPMorgan
Premium
The Fly
BridgeBio shares have ‘clear path’ to $90s, says JPMorgan
22d ago
BBIO
BridgeBio announces new data of Phase 3 ATTRibute-CM study at Heart Failure 2026
PremiumThe Fly
BridgeBio announces new data of Phase 3 ATTRibute-CM study at Heart Failure 2026
23d ago
BBIO
BridgeBio price target raised to $110 from $100 at H.C. Wainwright
PremiumThe Fly
BridgeBio price target raised to $110 from $100 at H.C. Wainwright
23d ago
BBIO
BridgeBio Pharma Signals Atruvio‑Led Turnaround
PremiumCompany Announcements
BridgeBio Pharma Signals Atruvio‑Led Turnaround
26d ago
BBIO
BridgeBio price target raised to $130 from $125 at Evercore ISI
PremiumThe Fly
BridgeBio price target raised to $130 from $125 at Evercore ISI
26d ago
BBIO
BridgeBio price target lowered to $94 from $98 at Morgan Stanley
PremiumThe FlyBridgeBio price target lowered to $94 from $98 at Morgan Stanley
26d ago
BBIO
BridgeBio Pharma Launches New $500 Million ATM Program
Premium
Company Announcements
BridgeBio Pharma Launches New $500 Million ATM Program
26d ago
8K
BBIO
BridgeBio price target raised to $114 from $100 at Bernstein
Premium
The Fly
BridgeBio price target raised to $114 from $100 at Bernstein
26d ago
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >